Indications
Rizmoic is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have previously been treated with a laxative.
Composition
- Active substance
- naldemedine tosilate
- International name (INN)
- naldemedine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rizmoic
- Active substance
- naldemedine tosilate
- ATC code
- A06AH05
- Therapeutic area
- Constipation
- Marketing authorisation holder
- Shionogi B.V.
- Status
- Authorised